Quick Answer
Sight Sciences, Inc. reported Stockholders Equity of $63.94 million for the year ending 2025.
- Sight Sciences, Inc. showed a decrease of -26.9% in Stockholders Equity from 2024 to 2025.
- This data is from Sight Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$63.80 million | Q2 2020: -$72.04 million | Q3 2020: -$79.96 million | Q1 2021: -$100.80 million | Q2 2021: -$117.29 million | Q3 2021: -$245.98 million | Q1 2022: $211.91 million | Q2 2022: $191.76 million | Q3 2022: $172.94 million | Q1 2023: $146.38 million | Q2 2023: $136.13 million | Q3 2023: $127.07 million | Q1 2024: $109.21 million | Q2 2024: $101.64 million | Q3 2024: $94.96 million | Q1 2025: $77.63 million | Q2 2025: $70.01 million | Q3 2025: $64.29 million.
- Over the full 7 years of available data (2019 to 2025), Sight Sciences, Inc.'s Stockholders Equity has grown by 216.9%.
- Historical annual values: Fiscal year 2025: $63.94 million | Fiscal year 2024: $87.52 million | Fiscal year 2023: $120.22 million | Fiscal year 2022: $160.08 million | Fiscal year 2021: $232.11 million | Fiscal year 2020: -$88.85 million | Fiscal year 2019: -$54.68 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: